BMO Capital analyst Simeon Siegel maintains Bath & Body Works (NYSE:BBWI) with a Outperform and raises the price target from $45 to $48.
WHO Recommends New COVID Booster Shots To Target XBB Variants, Despite Slower Uptake
An advisory group for the World Health Organization said the current crop of shots should be updated to target the currently dominant XBB strains for the